Clinical Trial Update: Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6 [Phase 3]

View source ↗

Summary

Phase 3 trial in Chinese patients with chronic hepatitis C evaluated response to pegylated interferon plus ribavirin across genotypes 1, 2/3, and 6; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED